Back to BlackRock, Inc. BlackRock, Inc.

TGTXTGTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in TG Therapeutics, Inc.

BlackRock, Inc. holds 22.1M shares of TGTX (TG Therapeutics, Inc.), worth $1.2B as of 2026-Q2. The position was decreased (-0.9% shares). TGTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1.2B

Current Shares

22.1M

Total Value Change

+$552.3M

Total Shares Change

+151,287

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
22.1M
-0.9%
$1.2B0.0%$54.94
0
2026-Q1
Increased
22.3M
+1.9%
$739.2M0.0%$28.88
32
2025-Q4
Increased
21.8M
+2.6%
$651.3M0.0%$29.75
32
2025-Q3
Decreased
21.3M
-2.4%
$769.5M0.0%$36.83
0
2025-Q2
Increased
21.8M
+1.5%
$785.1M0.0%$36.72
32
2025-Q1
Decreased
21.5M
-1.8%
$847.5M0.0%$39.86
0
2024-Q4
New
21.9M
-
$659.2M0.0%$31.44
44

Other major holders of TGTX: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used